Rheumatology Renal Medicine A
ACR/EULAR GPA/MPA Classification Criteria
Simplified scoring for ANCA-associated vasculitis (GPA/Wegener's). Score ≥5 classifies as GPA.
Score interpretation
GPA Not Classified 0–4
Score <5: Does not meet simplified GPA criteria
→ Consider MPA (MPO-ANCA), eosinophilic GPA (eGPA/Churg-Strauss), or other vasculitis
GPA (Wegener's) Classified 5–15
Score ≥5: Consistent with GPA
→ Urgent rheumatology/nephrology referral; ANCA titres; renal function; chest CT; consider rituximab or cyclophosphamide + high-dose steroids
Interpretation bands for the ANCA Vasculitis. Apply clinical judgement and local guidance.
References
- Robson JC, et al. 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Granulomatosis with Polyangiitis. Arthritis Rheumatol. 2022;74(3):393-399.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Drugs
- Avacopan · ANCA Vasculitis
- Rituximab (Nephrology) · ANCA Vasculitis / Nephrotic Syndrome
- Cyclophosphamide (Nephrology) · ANCA Vasculitis / Lupus Nephritis
- Avacopan (C5a Receptor Inhibitor — ANCA Vasculitis) · Complement C5a Receptor Antagonist (Oral Biologic)
- Colchicine · Anti-inflammatory — Neutrophilic Dermatoses / Vasculitis
Pathways
- Cutaneous Lupus Erythematosus · BAD; EULAR
- Osteoporosis / Fragility Fracture · NOGG 2021; NICE NG147; NG224
- Arteritic AION (Giant Cell Arteritis) · RCOphth; BSR
- Osteoarthritis Hip / Knee Management · NICE NG226 (2022)
- Lupus Nephritis · EULAR/ERA-EDTA 2019; KDIGO 2024
- Rheumatoid Arthritis Management · NICE CG79 2018 / EULAR 2022
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.